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Heavy metals, including lead, are significant for their toxicity to the environment 
and to organisms’ physiology. Lead has been shown to induce oxidative stress in cells 
through mitochondrial perturbation, as well as affecting heme homeostasis. The initial 
hypothesis was to study heme as an interorganellar signaling molecule in S. cerevisiae 
cells using a novel genetically encoded fluorescently heme sensor, specifically as a 
mitochondrial retrograde signaling molecule. In addition to labile and total heme 
measurements, growth and changes in the protein profile were also assessed to determine 
how lead affects the cells’ viability and stress response. It was found that there was no 
significant evidence of mitochondrial retrograde signaling with the labile heme pool, but 
that there was a preservation of the labile heme pool despite a marked decrease in total 
heme under lead conditions. The results support a model in which high affinity 
hemoproteins such as catalase are degraded under lead stress, while lower affinity ones 
such as glyceraldehyde phosphate dehydrogenase (GAPDH) are maintained. These 
results will help shape the understanding of the presence and purpose of the labile heme 










  The mitochondrion is a crucial organelle for cellular metabolism and intermediate 
metabolites. In addition to energy production, mitochondria are also involved in 
biosynthesis, metabolite conversion, and signal transduction3. The mitochondria and 
nucleus have a highly conserved endosymbiotic relationship in eukaryotes, with 
exchange of genetic material between these organelles. Mitochondrial retrograde 
signaling (MRS) is an intracellular pathway that enables mitochondria to communicate 
with the nucleus to regulate gene expression and enable the cell to adapt to changes in 
mitochondrial function. Previous studies have shown the significance of MRS in health 
and disease in its role in the pathogenesis and progression of diseases from cancer to 
neurodegenerative disorders1,2. Despite its importance in health and disease, the cellular 
mechanisms of MRS remain poorly understood. 
 One potential mechanism of MRS could be mediated by heme, a mitochondrial 
derived metabolite. Heme is an iron containing protein prosthetic group known to be an 
important cofactor for physiological processes such as electron transfer, gas binding and 
transport, and catalysis3. Heme is synthesized by the insertion of ferrous iron into the 
tetrapyrrole macrocycle of protoporphyrin IX, which is the product of a conserved eight 
step biosynthetic pathway that involves four mitochondrial and four cytosolic enzymes. 
The first committed step is the formation of ALA (d-aminolevulinic acid), which is then 
catalyzed by ALAD in the cytosol, and the final step involves insertion of the iron into 
the protoporphyrin ring by ferrochelatase in the mitochondrial matrix1. Intracellular heme 
trafficking is necessary for storage, sequestration, utilization, and incorporation into 
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hemoproteins2. The specific molecules and pathways necessary to facilitate heme 
transport and delivery have. yet to be elucidated.  
Heme’s role in MRS is proposed on the basis that there are many heme-dependent 
nuclear transcription factors, such as HAP1 in S. cerevisiae, that control processes such 
as respiration and energy metabolism and that heme synthesis is sensitive to 
mitochondrial function2. In this manner, mitochondrial dysfunction may be transmitted 
by changes in heme synthesis and availability, which is in turn sensed by heme-
dependent transcription factors that control cell metabolism.  
In order to study the role of heme in MRS, we established an experimental 
paradigm in which lead (Pb) is used to induce mitochondrial dysfunction and heme-
mediated MRS. Non-biological heavy metals such as lead (Pb) inhibit enzymes in the 
biosynthesis of heme (ALAD catalyzed step), and induce mitochondrial oxidative stress 
through accumulation of reactive oxygen species2,4. Mitochondrial stress then results in 
disruption of heme biosynthesis3. As a consequence, there may be changes in the activity 
of heme dependent nuclear transcription factors that control various processes3. 
Considering these pieces together motivates the question of how heavy metals would 
perturb heme dependent mitochondrial retrograde signaling. Yeast is a very useful model 
organism for studying lead toxicity because of its ability to be manipulated easily and its 
entirely sequenced genome. 
Total cellular heme can be conceptualized as being the summation of two pools, 
kinetically inert and labile heme. The former represents heme buried in the active sites of 
high affinity hemoproteins such as globins and cytochromes. The latter corresponds to 
heme that can be readily exchanged between different proteins, relevant for mobilization 
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in trafficking, utilization, and signaling. To probe the labile heme pool, the Reddi 
laboratory has developed a class of heme sensors. The first generation heme sensor (HS1) 
utilizes a tri-domain architecture composed of heme binding protein (cytochrome b562) 
and two fluorescent proteins, eGFP and mKATE2, which are quenched and unaffected by 
heme respectively. If heme is bound to the sensor, the ratio of eGFP to mKATE2 
fluorescence decreases. HS1 will be used to study the dynamics and availability of heme 
in a compartment-specific manner in the context of heavy metal induced stress. 
 The signals and relays that mediate MRS are not well understood and because heme 
is a mitochondrial derived metabolite and there are numerous heme-dependent nuclear 
transcription factors, we hypothesize that heme acts as a signaling molecule in MRS. The 
Reddi lab’s novel genetically encoded ratiometric fluorescent probes will be used to 
measure labile and in vivo heme trafficking and signaling throughout the yeast cell, an 
advantage over the previous lack of tools to examine heme signaling. Herein we establish 
a yeast model of lead toxicity, and utilize genetically encoded heme sensors and various 
biochemical approaches to probe the role of heme signaling in response to lead toxicity.  
  










METHODS AND MATERIALS 
 
Sources and Instrumentation 
 
All reagents and chemicals were obtained from Amresco, unless stated otherwise. 
Optical density measurements were carried out with a Cary 60 spectrophotometer and 
fluorescence readings were acquired with a Synergy H1 hybrid multi-mode microplate 
reader (BioTek). 
 
Organism and Culture Conditions 
 
The S. cerevisiae strains used in this study were derived from BY4741 from the 
yeast gene deletion collection (Thermo Fisher Scientific). Wild type (WT) yeast cells 
expressing empty vector (p415-GPD) and the HS1 sensor (p415-GPD-HS1) driven by the 
GPD promoter were primarily used, in addition to hem1∆ cells with a HEM1 deletion, 
previously created and tested strains were used6. For mitochondrial matrix or nuclear 
targeted sensors, strains fused with localization sequences to N-terminal Cox4 or C-
terminal SV4 were used6. For examining HAP1 activity, the CYC1 promoter is positively 
regulated by HAP1 and was used to drive eGFP expression. Cells were cultured in either 
yeast extract-peptone-dextrose with 2% glucose (YPD) or synthetic-complete media with 
2% glucose and lacking leucine (SC-LEU), with 15 mg/L ergosterol (Alfa Aesar) and 
0.5% tween-80 added to the media for growing hem1∆ cells. Incubation time was 15-16 




Transformation and Confirmation of Sensor Addition 
 
To transform cells with the desired sensor plasmid, cells from a single colony 
with the correct strain were cultured overnight in YPD, then 0.1 M LiOAc was added to 
the pellet to achieve a 100 OD/mL cell density. The solution (50 µL) was transferred to 
microcentrifuge tubes for HS1, HS1-M7A, no DNA, and EV, for each clone. Each 
solution was pelleted, the 0.1 M LiOAc removed, and 240 µL 50% PEG, 30 µL 1 M 
LiOAc, 10 µL ssDNA, and 50 µL all sterile water or 1 µL DNA and 49 µL sterile water 
were added onto the cell pellet and vortexed for a minute. The tubes were placed in 30°C 
water bath for 30 minutes, and 42°C water bath for 20 minutes, then vortexed and re-
suspended in 1 mL of sterile water. Each cell solution was added to SC-LEU plates with 
glass beads, incubated at 30°C for 2 days, and made into freezer stocks with 35% 
glycerol YPD. 
 To extract, amplify, and verify the correct DNA sequence the cell solution was 
incubated overnight at 30°C shaking at 220 rpm, then re-suspend in 1 mL of Solution 1 
(from Omega mini-prep box), and transferred to a microcentrifuge tube. After pelleting, 
an equivalent pellet volume of zirconium oxide (ZrO) beads was added, then subjected to 
bullet blending (Next Advance, 3 minutes, setting 8). To complete DNA extraction, the 
Omega mini-prep protocol was followed. PCR was conducted with 100 µL samples and 
0.8 µL Taq polymerase. Agarose gel (0.35 g agarose in 50 mL 1X TAE running buffer, 4 
µL EtBr) was made and run with 4 µL 100 bp DNA ladder, and samples with 10 µL 
amplified DNA and 2 µL 6X loading dye for about 80 minutes at 60 mA. The gel was 
imaged with a UV Transilluminator, then sent for sequencing (barcoding) if there were 
both 300 and 500 bp bands. 
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Lead Shock Protocol (Small Scale) 
 
This protocol was developed to grow yeast cells, treat cells with lead, and 
subsequently perform various assays (Figure 3.1). Cells transformed with sensor were 
cultured on SCE-LEU+ALA media at 30°C. They were grown overnight for 15-16 hours 
at 30°C, 220 rpm, then optical density was measured at 600 nm (about 5-9 OD/mL). A 
volume of cells was transferred for 15 OD to new 50 mL conical tubes, pelleted, and re-
suspended in 15 mL MES buffer to 1 OD/mL. MES was chosen based on previous work 
done by Van der Heggen5. Aqueous 100 mM Pb(NO3)2 (Alfa Aesar) to 500 µM was 
added and the tubes were left on the benchtop at room temperature (about 23°C) for 30 
minutes. The cells’ optical density at 600 nm was measured, then cells were transferred 
for 5 OD to new 50 mL conical tubes, pelleted, and re-suspended in 5 mL SCE-LEU to 1 
OD/mL. ALA was added if applicable. The tubes were placed in an incubator at 30°C, 
220 rpm for 4 hours. Afterwards, optical density was measured, 1 mL of cells were 
transferred to new microcentrifuge tubes, pelleted, and re-suspended in a calculated 
volume of 1x PBS to 7 OD/mL. This solution (100 µL) was added to wells in a black 
bottomed Fluotrac 96 well plate and fluorescence was measured with a 5 minute kinetic 
run at the wavelengths for eGFP and mKATE.  
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Figure 3.1. Simplified scheme illustrating the lead shock protocol. 
 
 
Catalase Enzyme Activity 
 
To assess the catalase activity in the cells under each experimental condition, 
catalase enzyme activity gels were run. Different cell volumes were transferred to locking 
microcentrifuge tubes to normalize to the lowest OD/mL (10< OD/mL). Cells were lysed 
with phosphate lysis buffer, ZrO beads, and bullet blending. A Bradford Protein 
Concentration Assay was performed to determine the lysate protein concentration. 
Samples were prepared to a total volume of 13 µL (15 µg protein, 2.6 µL 5X SOD 
loading dye, lysis buffer). A 10% tris-glycine gel (Invitrogen) was run at 13 mA with 
Tris-glycine pH 7 running buffer. The gel was stained immediately for 2 minutes with a 
catalase staining solution containing 1 part Dopamine (20mg/mL) in pH 8 0.2 M KPi 
buffer, 1 part para-phenylenediamine (3.5mg/mL) in pH 8 0.2M KPi, 1 part 15 % H2O2, 




To determine equal loading and total protein profile, samples were prepared with 
a total volume of 10 µL (5 µg lysate, 2 µ 5X sodium dodecyl sulfate (SDS) loading dye, 
1 µL dithiothreitol (DTT), 1X phosphate buffered saline (PBS)) and ran a 10% 
polyacrylamide gel (Invitrogen) (30 mA) for about 80 minutes. The gel was stained with 
Coomassie staining solution (0.1% (w/v) Coomassie blue R350, 20% (v/v) methanol, and 
10% (v/v) acetic acid), heated in microwave for 2 minutes, then replaced with Coomassie 
de-staining solution, and heated in microwave for 2 minutes. Fresh de-staining solution 
(50% (v/v) methanol in water with 10% (v/v) acetic acid) was added, the gel was left on a 
rocking platform overnight, and then imaged with transilluminator.  
 
High Performance Liquid Chromatography (HPLC) 
HPLC was used to measure and quantify total intracellular heme. The cell pellet 
was re-suspended from -80°C (output of large scale lead protocol experiment) in 150 µL 
sterile water. Optical density (using 1/400-1/600 dilution) was measured and acetone-HCl 
(9.75 mL acetone and 0.25 mL concentrated HCl) was used to lyse cells. The cell 
solution (50 µL)  was combined with 50 µL 0.1% trifluoroacetic acid (TFA) in a 1:1 
mixture of water and acetonitrile. A heme standard (hemin chloride (Calbiochem/Merck) 
in 0.1 M NaOH) with nanomolar concentration was prepared. An Agilent 1260 Infinity 
HPLC with a diode array detector and C18 column was used. The solvent was switched 
between 100% acetonitrile, 0.1% TFA to clear the line and 50% acetonitrile in water, 
0.1% TFA to run the sample at a 1 mL/min flow rate. Heme was quantified using the 
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hemin chloride standard using the peak areas at the characteristic retention time of heme 
of 3.4 minutes. 
 
Total Reflection X-ray Fluorescence (TXRF) Elemental Analysis 
Cellular lead uptake was quantified by TXRF spectroscopy. The cell pellet was 
re-suspended from -80°C (output of large scale lead protocol experiment) in 150 µL 
sterile water. Optical density (using 1/400-1/600 dilution) was measured, then 9 µL cell 
solution (100< OD/mL) was transferred to new microcentrifuge tube and 1 µL Ga (10 
ppm) was added. The quartz disks were prepared by adding 10 µL silicone, then heating 
on hot plate (about 5 minutes). Cell solution with Ga (2 µL) was added to center of the 
















Yeast Model of Lead Toxicity 
 
We first sought to establish a yeast model of lead toxicity to probe heme-based 
MRS in response to lead stress. Towards this end, we determined the median lethal dose 
(LD50) of lead required to kill half of the yeast culture was 500 µM Pb(NO3)2 (Figure 
4.1). Viability was measured by determining the ability of the yeast cells to grow and 

















Figure 4.1. Growth density after lead shock (0 to 1000 µM) and 20 hour recovery in fresh 
SCE-LEU media.  
 
 
Total Reflection X-Ray Fluorescence Spectrometry (TXRF) verified and 
measured the amount of lead transported into cells. Figure 4.2 shows that lead 
significantly accumulated in the cells treated with lead and that there were virtually 
undetectable levels in cells without lead treatment. Figure 4.2 further shows that the 

















Figure 4.2. Concentration (M) of lead per WT-HS1 or hem1Δ-HS1 cell, with either 0 µM 
(-) or 500 µM (+) lead. ALA concentrations were 0 µM (-), 10 µM (+), and 200 µM (++). 
The samples with +Pb had very similar amounts of lead uptake (0.007 to 0.011 M/cell), 
while the -Pb samples had virtually no lead uptake.  
 
 
Effects of Lead Toxicity on Labile and Total Heme 
 
 
Having established a yeast model for lead toxicity, we next sought to determine 
the impact lead has on total and labile heme. As expected, we observed that total heme 
levels are depleted in lead treated WT cells to undetectable levels (Figure 4.3). This is 
due to several heme biosynthetic enzymes being inhibited by lead. However, rather 
surprisingly, labile heme pools are largely preserved as determined by genetically 
encoded fluorescent sensors. 
The amount of total heme in cells was quantified using HPLC and a hemin 
chloride standard. WT cells exhibit a cellular concentration of heme of 536 nM and lead 
treatment resulted in undetectable levels of heme similar to the hem1Δ strain, which 



















ratio in the lead treated cells, indicating an increase in the labile heme pool, in contrast to 
the decrease in total heme concentration.  
 
 
Figure 4.3. The concentration of heme (nM) per cell for WT-HS1 with either 0 or 500 


















































Labile Heme in Cellular Compartments 
 
The fluorescence ratios after lead shock and 4 hour recovery were measured in 
cells with sensor targeted to the cytosol, mitochondria (cox4), and nucleus (NLS). The 
cytosol and nucleus showed similar relative eGFP/mKATE values between the ±Pb 
conditions, with an irregular negative ratio value for the lead treated cells with 
mitochondrial sensor (Figure 4.5). The lack of significant change in cytosolic labile heme 
pools was especially key in the decision to shift the direction of the project away from 




Figure 4.5. Fluorescence ratios of WT cells with HS1 sensor targeted to the cytosol, 
mitochondria, and nucleus under ±Pb. 
 
 
Effect of Lead on Heme-Regulated Processes 
 
Having established that the labile heme pool is preserved in response to lead 
toxicity, we next sought to determine if lead stress effects heme-regulated functions. 
Towards this end, we sought to assay catalase activity, a heme dependent enzyme, and 






















As shown in Figure 4.6, there is drastically less catalase activity in the WT-HS1 
cells that underwent lead shock. Catalase was the only high affinity hemoprotein 
available to study in yeast. 
Presently, the only known heme dependent transcription factor in S. cerevisiae is 
HAP1. Therefore, cells with eGFP driven by cyc1, an indicator of HAP1 activity, were 
subjected to the lead shock protocol and the fluorescence level results are proportional to 
HAP1 activity. In the WT-pcyc1-eGFP cells, there was a decrease in HAP1 activity with 
lead treatment (Figure 4.7). 
 
Figure 4.6. The stained catalase activity gel with 15 µg protein loaded. Qualitatively, the 




Figure 4.7. The fluorescence results for WT-pcyc1-eGFP after for cells with and without 
lead shock. There is a decrease in HAP1 activity with addition of lead. 
 
 
Total Protein Analysis 
 
One mechanism in which to investigate why the total heme pool is depleted while 
the labile heme pool is preserved during lead stress is to probe protein abundance using 
SDS-PAGE analysis and tandem mass spectrometry.  If the high affinity hemoproteins, 
accounting for a large fraction of heme in cells, are selectively degraded, this would help 
explain the mechanism behind the heme pool discrepancy. Qualitatively examining the 
Coomassie gel, it appears that there is significantly less protein in WT-HS1 cells with Pb, 
except for two bands (Figure 4.8). The higher molecular weight (MW) band has 
consistent intensity across all the samples, but the lower molecular weight one appears to 
be stronger in WT with Pb. Protein ID done in collaboration with the Torres lab at 



































Figure 4.8. The stained Coomassie total protein gel. Qualitatively there is significantly less 
protein in WT-HS1 +Pb, with the exception of two bands, which were determined to be 















DISCUSSION AND CONCLUSION 
The original hypothesis was that heme acts as a MRS molecule after lead induced 
stress. However, the results do not indicate a clear connection between lead shock and 
changes in labile heme between the cytosol, mitochondria, and nucleus. The cytosol did 
experience a decrease in labile heme, however, this was not matched with a change in the 
nucleus or mitochondrial labile heme pools. Unknown factors caused the negative 
eGFP/mKATE ratio in the 500 µM Pb(NO3)2 with mitochondrial sensor cells, and it was 
generally difficult to probe these compartments in a dependable and quantitative manner. 
Future experiments should be done to continue exploring MRS with other techniques in 
combination with the HS1 sensor. 
The results instead suggest a previously undiscovered discrepancy in total and 
labile heme tracking together under lead stress. A few key experiments were performed 
to provide a basis of support for the results. It was found that 500 µM Pb(NO3)2 results in 
a LD50 dose that can still induce changes in heme and retain viability of some cells. 
TXRF elemental analysis verified that the lead uptake was working as expected, without 
influence from the presence or lack of heme. 
When examining the relative amounts of total and labile heme between WT-HS1 
with and without Pb(NO3)2, the total heme is completely knocked down with the addition 
of lead, while labile heme remains preserved to similar (slightly lower) levels as WT 
without Pb(NO3)2. It does not appear that this preserved labile heme is being used for 
HAP1 transcription factor activity because HAP1 activity decreased in lead treated cells. 
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Catalase is a high affinity hemoprotein that also showed significant diminishment in 
activity in the lead treated cells.  
 Interestingly, it was found that enolase and GAPDH proteins were maintained in 
lead-treated cells, when all other proteins were greatly reduced. GAPDH is a lower 
affinity hemoprotein found to buffer intracellular heme and regulate the heme-dependent 
transcription factor heme activator protein (Hap1p) activity6. Enolase is mainly a 
cytosolic glycolytic enzyme, but has also been found to be involved in vacuole fusion; a 
hypothesis for future experiments is the role of the vacuole and vacuole transporters in 


















The established results provide a firm foundation for many promising and 
exciting studies to further investigate the mechanisms and significance of heme 
trafficking under lead toxicity. Another approach is to remove the heme pools with 
biosynthetic inhibitors such as succinyl acetone and very high affinity but non-active 
proteins like cytb562, to assess how lead’s effect on cell growth and protein activity 
changes.  
The total heme experiments using HPLC need further replication and reduced 
error. In conjugation with HPLC, Coomassie, catalase, and GAPDH activity should be 
assessed by their respective gels to gain a clearer picture of the mechanism or pathway by 
which labile heme is being preserved and what function it is being preserved for. Some of 
the genes controlling proteins for heme transport and degradation are known and can be 
knocked out to find the impact on cells under lead toxicity. Tdh3Δ and pug1Δ strains 
would remove the ability of cells to synthesize glyceraldehyde-3-phosphate dehydrogenase 
and enable protoporphyrin uptake, fixing part of the labile heme pool flux8,9. Hmx1Δ 
would inactivate heme oxygenase, the enzyme that degrades heme, thus removing 
another source of the labile pool losing heme10. Expanding the scope of the study to 
mammalian cells would also be a worthwhile future study. 
Preliminary work is being done using heme agarose beads with affinity 
chromatography to quantitate GAPDH changes in conjunction with mass spectrometry 
(Stable isotope labeling with amino acids in cell culture (SILAC)) to determine proteome 
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changes caused by lead toxicity. Additional studies are needed to completely elucidate 
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